CONMEDCNMD
Market Cap: $2.29B
About: Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Employees: 4,000
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
5% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 106
0.02% more ownership
Funds ownership: 115.75% [Q1] → 115.77% (+0.02%) [Q2]
2% less funds holding
Funds holding: 293 [Q1] → 286 (-7) [Q2]
13% less capital invested
Capital invested by funds: $2.85B [Q1] → $2.47B (-$382M) [Q2]
16% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 43
47% less call options, than puts
Call options by funds: $4.18M | Put options by funds: $7.91M
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Piper Sandler Matt O'Brien 50% 1-year accuracy 22 / 44 met price target | 8%upside $80 | Overweight Maintained | 1 Aug 2024 |
Stifel Rick Wise 68% 1-year accuracy 19 / 28 met price target | 2%upside $76 | Buy Maintained | 1 Aug 2024 |
Wells Fargo Vik Chopra 20% 1-year accuracy 1 / 5 met price target | 4%downside $71 | Equal-Weight Maintained | 1 Aug 2024 |
Needham Mike Matson 64% 1-year accuracy 72 / 113 met price target | 31%upside $97 | Buy Maintained | 1 Aug 2024 |
Needham Mike Matson 64% 1-year accuracy 72 / 113 met price target | 43%upside $106 | Buy Maintained | 25 Jul 2024 |
Financial journalist opinion
Based on 6 articles about CNMD published over the past 30 days